Jun 20, 2025
There’s a common belief in pharma automation that as long as the machine runs, the software is “fine.” But that mindset rarely survives a regulatory audit.
GAMP 5 compliance demands more: provable, risk-managed, and lifecycle-controlled systems. At the core of this lies the PLC layer – the code that drives core pharma manufacturing activities like fluid flow, dosing logic, CIP sequences, and safety interlocks.
Yet in many vendor ecosystems, PLC programming remains detached from formal software lifecycle practices. It often gets patched, duplicated, or versioned in silos and documented only after the fact.
The real challenge is this: GAMP 5 doesn’t just ask if the code works. It demands to know why the code was written, how it ties to risk, and what traceability exists from user requirements to implementation.
Vendors who understand this shift have started evolving their development approach. They build solutions that inspire lasting confidence – from the first User Requirements Specification (URS) review to the last rung of ladder logic.